Status:

WITHDRAWN

Steroid Injection for the Treatment of Greater Trochanteric Pain Syndrome

Lead Sponsor:

Emory University

Conditions:

Bursitis

Eligibility:

All Genders

17+ years

Phase:

PHASE4

Brief Summary

The objective of this study is to conduct a randomized, single-blinded placebo controlled trial comparing two modalities for the treatment of pain and mobility associated with trochanteric bursitis: (...

Detailed Description

Trochanteric bursitis is an inflammation of the bursal sac overlying the greater trochanter of the femur. The etiology of this disease is unknown, but it is clinically characterized by chronic aching ...

Eligibility Criteria

Inclusion

  • Adult patients with tenderness at the greater trochanter

Exclusion

  • Subjects \< 17 years of age
  • Subjects with previous surgery to the greater trochanter
  • Subjects allergic to Lidocaine, Marcaine, or Depomedrol

Key Trial Info

Start Date :

March 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2010

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00863889

Start Date

March 1 2009

End Date

February 1 2010

Last Update

September 23 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dr. Tom Bradbury

Atlanta, Georgia, United States, 30306

Steroid Injection for the Treatment of Greater Trochanteric Pain Syndrome | DecenTrialz